Lutathera Market By Indication (Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), Bronchial Neuroendocrine Tumors, Others), By Route of Administration (Intravenous, Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Drug Stores), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Cancer Treatment Centers, Academic and Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Mar 2025 | Report ID: MI2402 | 100 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Indication

  • Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
  • Bronchial Neuroendocrine Tumors
  • Others

By Route of Administration

  • Intravenous
  • Intramuscular

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Drug Stores

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Cancer Treatment Centers
  • Academic and Research Institutes

By Region

North America

  • The U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea

Latin America

  • Brazil
  • Argentina
  • Mexico

MEA

  • Saudi Arabia
  • United Arab Emirates
  • South Africa

List of Companies

  • Novartis
  • Ipsen
  • Siemens Healthineers
  • GE Healthcare
  • Progenics Pharmaceuticals
  • Lantheus Medical Imaging
  • Theragnostics
  • Nordic Nanovector
  • Canberra (Mirion Technologies)
  • Blue Earth Diagnostics

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing